Skip to content

Dextrose Effect on Postoperative Nausea and Vomiting (PONV)

The Impact of Timing and Dosing of Dextrose Solution on Postoperative Nausea and Vomiting.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04726436
Enrollment
120
Registered
2021-01-27
Start date
2021-01-25
Completion date
2021-05-01
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Nausea and Vomiting

Brief summary

The aim of this study to assess which time and dose of dextrose solution more effective in decreasing postoperative nausea and vomiting.

Detailed description

All patients signed informed consent after excluding patients not candidate for the study.patients were divided to three groups, taking either 0.9% saline as control group(group C), dextrose 5%(group D5) or dextrose 10%(group D10).

Interventions

One hour before operation, patients were given dexrose 5%100/hour only for 2 hours to end at about middle of surgery

One hour before operation, patients were given dexrose 10 %100/hour only for 2 hours to end at about middle of surgery

OTHERSaline placebo

One hour before operation, patients were given normal saline100/hour only for 2 hours to end at about middle of surgery

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Female non-smokers adults (age 18-65 years) * ASA I-II who were listed for elective surgery under general anesthesia (surgery which is risk for PONV).

Exclusion criteria

* Severe hypertension * Coagulopathy * Significant hepatic or renal disease * Diabetes mellitus or abnormal blood glucose on the morning of surgery * Withdrawal of consent * Severe intraoperative hypotension requiring large volume intravascular fluid treatment * Protocol violations including nitrous oxide administration.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative nausea and vomiting within 24 hour24hour after surgeryNumber of participants who experienced PONV grade ≥2 as assessed by PONV score . The PACU nurses assessed and documented PONV using a Verbal Descriptive Scale, which correlates to visual analog nausea scores, with an objective measure of severity: 0 = no PONV: patient reports no nausea and has had no emesis episodes; 1 = mild PONV: patient reports nausea but declines antiemetic treatment; 2 = moderate PONV: patient reports nausea and accepts antiemetic treatment; and 3 = severe PONV: nausea with any emesis episode (retching or vomiting). The score was obtained at 0, 30, 60, 90, and 120 minutes after PACU arrival; thus 5 scores were recorded during PACU stay. A 24-hour PONV assessment that elicited any nausea and emesis episode since PACU discharge was obtained by a blinded investigator by telephone or in person at the patient's bedside (delayed PONV).

Secondary

MeasureTime frameDescription
Number of doses of antiemetics required to control PONV.24hour postoperativeFrequency of doses of antiemetics required to control postoperative nausea and vomiting, initial antiemetic treatment was 10 mg slow IV metoclopramide for occurred nausea or 4 mg IV ondansetron for occurred nausea & vomiting or if the previous treatment failed for nausea
Number of classes of antiemetics24 hour postoperativeFrequency of classes of antiemetics required to control postoperative nausea and vomiting, Initial antiemetic treatment was 10 mg slow IV metoclopramide for occurred nausea or 4 mg IV ondansetron for occurred nausea & vomiting or if the previous treatment failed for nausea

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026